Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
March 15 2022 - 9:26AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO SECTION 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of March 2022
Commission File Number: 001-39950
Evaxion Biotech A/S
(Exact Name of Registrant as Specified
in Its Charter)
Dr. Neergaards Vej 5f
DK-2970 Hoersholm
Denmark
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file
annual reports under cover of Form 20-F or Form 40-F.
Form 20-F x
Form 40-F ¨
Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(1): ¨
Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(7): ¨
Announcement of Appointment of Two Senior Management
Team Members
On March 14, 2022, Evaxion Biotech
A/S issued a press release announcing the appointment of Bo Karmark as its new Chief Financial Officer and Jesper Nyegaard Nissen as
its Chief Operating Officer.
INCORPORATION BY REFERENCE
This report on Form 6-K shall
be deemed to be incorporated by reference in that certain registration statement on Form S-8 (File No. 333-255064) (including
any prospectus forming a part of such registration statement) of Evaxion Biotech A/S ( the “Company”) and to be a part thereof
from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished.
Furnished
as Exhibit 99.1 to this Report on Form 6-K is the Company’s Press Release dated March 14, 2022, related to its appointments
of two senior management team members.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
Evaxion
Biotech A/S |
|
|
Date: March
15, 2022 |
By: |
/s/
Niels Iversen Møller. |
|
|
Name: Niels Iversen Møller |
|
|
Title: Chief Financial
Officer |
Evaxion Biotech AS (NASDAQ:EVAX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Evaxion Biotech AS (NASDAQ:EVAX)
Historical Stock Chart
From Jul 2023 to Jul 2024